Cargando…

Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model

BACKGROUND: Hepatocellular carcinoma (HCC) is an inflammation-associated tumor involved in immune tolerance and evasion in the immune microenvironment. Immunotherapy can enhance the immune response of the body, break immune tolerance, and then recognize and kill tumor cells. The polarization homeost...

Descripción completa

Detalles Bibliográficos
Autores principales:	kong, Panpan, Yang, Huan, Tong, Qing, Dong, Xiaogang, Yi, Mamumaimaitijiang-Abula, Yan, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423131/ https://www.ncbi.nlm.nih.gov/pubmed/37306737 http://dx.doi.org/10.1007/s00432-023-04949-y

Ejemplares similares

NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling
por: Tong, Qing, et al.
Publicado: (2023)

Expression and Prognostic Value of Tumor-Infiltrating Lymphocytes and PD-L1 in Hepatocellular Carcinoma
por: Nie, Hanxiao, et al.
Publicado: (2021)

Construction of an M2 macrophage-related prognostic model in hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

Tumor–stroma ratio predicts prognosis and PD-L1 expression in hepatocellular carcinoma
por: Wang, Dong, et al.
Publicado: (2023)

Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
por: Pu, Yunzhou, et al.
Publicado: (2022)

Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors
por: Fan, Yangwei, et al.
Publicado: (2016)

Prognostic significance of LRRC1 in hepatocellular carcinoma and construction of relevant prognostic model
por: Cai, Qingshan, et al.
Publicado: (2023)

Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection
por: Shu, Qing‐Hua, et al.
Publicado: (2016)

The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system
por: Wang, Qiaona, et al.
Publicado: (2023)

Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma
por: Kong, Fanhua, et al.
Publicado: (2022)

Prognostic impact of sarcopenia in patients with hepatocellular carcinoma treated with PD-1 inhibitor
por: Guo, Yusheng, et al.
Publicado: (2022)

PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma
por: Lu, Li-Gong, et al.
Publicado: (2022)

Distinct patterns and prognostic values of tumor-infiltrating macrophages in hepatocellular carcinoma and gastric cancer
por: Li, Jin-Qing, et al.
Publicado: (2017)

Tumor‐associated macrophages regulate the function of cytotoxic T lymphocyte through PD‐1/PD‐L1 pathway in multiple myeloma
por: Zhang, Jiangbo, et al.
Publicado: (2022)

Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors
por: Winograd, Paul, et al.
Publicado: (2020)

Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages
por: Lu, Di, et al.
Publicado: (2019)

PD-L1-Mediated Immunosuppression in Hepatocellular Carcinoma: Relationship with Macrophages Infiltration and Inflammatory Response Activity
por: Guo, Shuang, et al.
Publicado: (2022)

PD-L1 combined with HDAC9 is a useful prognostic predictor in hepatocellular carcinoma
por: Yang, Zhao, et al.
Publicado: (2021)

TRIM36 inhibits tumorigenesis through the Wnt/β-catenin pathway and promotes caspase-dependent apoptosis in hepatocellular carcinoma
por: Tong, Qing, et al.
Publicado: (2022)

GOLM1 exacerbates CD8(+) T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages
por: Chen, Jinhong, et al.
Publicado: (2021)

HAMP as a Potential Diagnostic, PD-(L)1 Immunotherapy Sensitivity and Prognostic Biomarker in Hepatocellular Carcinoma
por: Chen, Guoming, et al.
Publicado: (2023)

PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma
por: Deng, Rui, et al.
Publicado: (2020)

Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jung, Hae Il, et al.
Publicado: (2017)

Construction of a Prognostic Model for Hepatocellular Carcinoma Based on Immunoautophagy-Related Genes and Tumor Microenvironment
por: Sun, Zhen, et al.
Publicado: (2021)

Clinical outcomes and influencing factors of PD-1/PD-L1 in hepatocellular carcinoma
por: Wang, Jiting, et al.
Publicado: (2021)

PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
por: Li, Qian, et al.
Publicado: (2022)

Higher Number of Tumor-Infiltrating PD-L1+ Cells Is Related to Better Response to Multikinase Inhibitors in Hepatocellular Carcinoma
por: Han, Ji Won, et al.
Publicado: (2023)

CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
por: Yugawa, Kyohei, et al.
Publicado: (2020)

PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
por: Kim, Ki Hyung, et al.
Publicado: (2019)

The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma
por: Huang, Yu, et al.
Publicado: (2021)

Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis
por: Ding, Wei, et al.
Publicado: (2019)

Elevation of spermine remodels immunosuppressive microenvironment through driving the modification of PD-L1 in hepatocellular carcinoma
por: Shi, Hong-Xiang, et al.
Publicado: (2022)

Association of PD-L1 and HIF-1α Coexpression with Poor Prognosis in Hepatocellular Carcinoma
por: Dai, Xiaomeng, et al.
Publicado: (2018)

M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma
por: Qu, Xiaodong, et al.
Publicado: (2022)

The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and α-SMA
por: Fang, Min, et al.
Publicado: (2018)

Macrophages M1-Related Prognostic Signature in Hepatocellular Carcinoma
por: Zhang, Hao, et al.
Publicado: (2021)

An M0 macrophage-related prognostic model for hepatocellular carcinoma
por: Zhang, Yiya, et al.
Publicado: (2022)

Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
por: Lu, Jia-Cheng, et al.
Publicado: (2021)

Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma
por: Zhang, Xi, et al.
Publicado: (2021)

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
por: Ng, Harry Ho Man, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3jnb3s3nns2oqbnsfo2q2tjb33